Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. (Q43424414)
Jump to navigation
Jump to search
scientific article published in September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. |
scientific article published in September 2006 |
Statements
1 reference
Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. (English)
1 reference
Lennart Gustafsson
1 reference
Luc Hessel
1 reference
Jann Storsaeter
1 reference
Patrick Olin
1 reference
1 September 2006
1 reference
1 reference
118
1 reference
3
1 reference
978-984
1 reference
Identifiers
1 reference
1 reference